StockData
Inventiva S.A. logo

Inventiva S.A. (IVA) shareholders

IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 1/30
$3.22−0.10 (-3.01%)

Close on Nov 17, 2026Market cap $622.22MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
87M
Shares held, 13F filers
Institutional holders
88
31 new, 7 sold out
Net institutional buying
37M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Joseph Anderson
Joint filing with Sofinnova Partners SAS, a French corporation (8.60%), Antoine Papiernik (8.60%) and 4 more
19,086,0508.60%13G (passive) amendmentDec 31, 2025
BioDiscovery 6 FPCI
Joint filing with Andera Partners (6.70%), Stephane Bergez (6.70%) and 1 more
15,929,4766.70%13G (passive) amendmentSep 30, 2026
Invus Public Equities Advisors, LLC
Joint filing with Invus Public Equities, L.P. (10.60%), Invus Global Management, LLC (10.60%) and 2 more
14,814,81310.60%13G (passive) amendmentJun 30, 2025
Andera Partners
Joint filing with BioDiscovery 6 FPCI (7.70%), Stephane Bergez (7.70%) and 1 more
14,114,4767.70%13G (passive) amendmentDec 31, 2025
Srinivas Akkaraju13,540,1947.40%13D (active) amendmentNov 17, 2025
David Kroin
Joint filing with Deep Track Capital, LP (6.07%), Deep Track Biotechnology Master Fund, Ltd. (6.07%)
11,668,9836.07%13G (passive)Jan 23, 2026
Dr. Jeffrey R. Jay, M.D.
Joint filing with Great Point Partners, LLC (7.42%), Ms. Lillian Nordahl (7.42%)
10,576,8277.42%13G (passive)May 5, 2025
Finny Kuruvilla, M.D. Ph. D.
Joint filing with Eventide Asset Management, LLC (6.70%), Robin C. John (6.70%)
10,118,5176.70%13G (passive)May 9, 2025
Bvf Partners L P/Il
Joint filing with Bvf Inc/Il (6.10%), Lampert Mark N (6.10%) and 1 more
8,545,4996.10%13D (active) amendmentMay 7, 2025
Rick Yang
Joint filing with New Enterprise Associates 17, L.P. (6.00%), NEA Partners 17, L.P. (6.00%) and 12 more
8,350,7306.00%13D (active) amendmentMay 7, 2025
Samsara BioCapital, L.P.
Joint filing with Samsara BioCapital GP, LLC (5.90%), Srinivas Akkaraju (5.90%)
8,161,9425.90%13D (active)May 7, 2025
Cedric Moreau
Joint filing with Sofinnova Crossover I SLP (7.20%), Sofinnova Partners SAS, a French corporation (7.20%) and 4 more
7,792,3077.20%13G (passive) amendmentDec 31, 2024
Yiheng Capital Partners, L.P.
Joint filing with Yiheng Capital, LLC (5.46%), Yiheng Capital Management, LP (5.46%) and 1 more
7,597,1485.46%13G (passive) amendmentSep 30, 2025
Siren, L.L.C.
Joint filing with Invus Public Equities, L.P. (7.80%), Invus Public Equities Advisors, LLC (7.80%) and 2 more
7,407,4067.80%13G (passive)Oct 17, 2024
Francois Xavier Mauron
Joint filing with Andera Partners (6.50%), BioDiscovery 6 FPCI (6.50%) and 1 more
6,148,1476.50%13G (passive)Oct 17, 2024
Joseph Edelman
Joint filing with Perceptive Advisors LLC (5.80%), Perceptive Life Sciences Master Fund, Ltd. (5.80%)
5,555,5555.80%13G (passive)Dec 13, 2024
Yuanshan Guo
Joint filing with Yiheng Capital Partners, L.P. (8.31%), Yiheng Capital, LLC (8.31%) and 1 more
4,331,1968.31%13G (passive) amendmentSep 30, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IVAValueChange% of portfolio
Caligan Partners LP8,163,191–$30.86M+3,188,2851.45%
Samsara BioCapital, LLC6,314,805–$23.87M+1,120,0001.96%
Nantahala Capital Management, LLC5,372,786–$20.31MNew0.34%
Paradigm Biocapital Advisors LP4,000,000–$15.12M–0.28%
Andera Partners3,633,181–$13.73M+1,815,0006.65%
ADAR1 Capital Management, LLC3,606,656–$13.63M+1,432,2580.62%
Millennium Management LLC3,512,174–$13.28M+524,5610.00%
Trails Edge Capital Partners, LP2,657,997–$10.05M–1.60%
Franklin Resources Inc2,642,611–$9.99M+181,0460.00%
Squadron Capital Management LLC2,435,000–$9.20M+1,900,0002.86%
Woodline Partners LP2,323,149–$8.78MNew0.03%
abrdn plc2,307,773–$8.72MNew0.01%
UBS Group AG2,305,192–$8.71M−13,5010.00%
Boothbay Fund Management, LLC2,003,782–$7.57M+533,3750.10%
Patient Square Capital LP1,967,171–$7.44MNew1.15%
NEXTBio Capital Management LP1,787,984–$6.76M+454,5003.11%
Citadel Advisors LLC1,784,566–$6.75M+1,719,6160.00%
Ameriprise Financial Inc1,697,148–$6.42M+852,9330.00%
Point72 Asset Management, L.P.1,683,012–$6.36M+726,7910.01%
Integral Health Asset Management, LLC1,520,000–$5.75M+1,120,0000.23%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 20268887M31 / 367 / 741M4M
Q1 20266552M22 / 2110 / 1010M5M
Q4 20255347M38 / 61 / 044M2M
Q3 2025155M5 / 31 / 20M0M
Q2 2025125M4 / 22 / 00M0M
Q1 202585M1 / 12 / 00M1M
Q4 202475M2 / 20 / 21M0M
Q3 202475M1 / 11 / 10M0M
Q2 202475M0 / 21 / 10M0M
Q1 202485M2 / 21 / 30M0M
Q4 202395M1 / 22 / 00M0M
Q3 202385M2 / 11 / 30M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

9 funds held IVA in Q2 2026, 14% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of IVAValue% of fundAs of
Franklin Biotechnology Discovery Fund1,014,919–$4.55M0.39%Jul 31, 2026
Fidelity Advisor Biotechnology Fund685,400–$3.07M0.14%Jul 31, 2026
Simplify Propel Opportunities ETF313,483–$1.18M1.53%Jun 30, 2026
Fidelity Small Cap Stock Fund154,400–$691.71K0.05%Jul 31, 2026
Artisan International Small-Mid Fund144,292–$545.42K0.02%Jun 30, 2026
Fidelity Series Small Cap Core Fund136,161–$610.00K0.04%Jul 31, 2026
Blackstone Alternative Multi-Strategy Fund42,752–$161.60K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund34,355–$169.37K0.00%May 31, 2026
Harbor Health Care ETF33,996–$152.30K0.37%Jul 31, 2026
ActivePassive International Equity ETF8,145–$40.15K0.00%May 31, 2026
Fidelity Small Cap Stock K6 Fund2,400–$10.75K0.05%Jul 31, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
10M shares short
Days to cover
3.5
At 3M shares a day
Change since last report
+26.9%
From 8M shares
Short volume, 20 days
37.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Inventiva's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,900 shares on Aug 28, 2026 over the last 90 days.

See a number that looks wrong?